When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BioMarin product revenue has begun to decline. The outlook and guidance for 2021 is consistent with the modest decline reported in the first quarter.
The next catalyst is likely November 2021 which is the scheduled PDUFA date for Vosoritide.
Roctavian remains the most significant potential catalyst. Management is guiding to a possible submission in mid-2022 and an accelerated six-month FDA review cycle.